Could hackers set their sights on your medical device?

Cara Livernois | | Health Exec | Cybersecurity

Hackers are best known for stealing patient data through computers, but they may have added an entirely new avenue to encroach on your privacy—by infiltrating medical devices.

The first public acknowledgment of a potential attack on a medical device came from Johnson & Johnson in regards to its insulin pump. The company said hackers may be able to use a security bug that gains control of the pump and could be used to administer insulin to overdose patients.

A Johnson & Johnson spokesman told NBC News that newer devices are encrypted with more security. He also said a hacker would have to be within 25 feet of the 12-year-old device to affect the signal.

Read the full story by clicking the link below:

Insulin Pump Vulnerable to Hacking, Johnson & Johnson Warns

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Hackers were inside an Iowa hospital’s network for two weeks
Microsoft: Ransomware hit nearly 400 healthcare entities this year—a 300% rise since 2015
Feds make it official: Change data breach was the largest in healthcare history, impacting 100M
CMS contractor takes $1.2M loss after data breach, DOJ lawsuit
Boston Children's physician group suffers data breach
Homeland Security warns healthcare organizations of hackers using 'password spraying' tactic

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup